Notes in 20 Malignant Hyperthermia

To Subscribe, use this Key

Status	Last Update	Fields
Published	12/13/2023	While the most reliable sign of malignant hyperthermia is a rise in the {{c2::ETCO2}}, the first sign is usually {{c1::tachycardia}}.
Published	12/13/2023	A newer formulation of dantrolene, {{c1::Ryanodex}}, requires only 1 vial for the initial dose of dantrolene.
Published	12/13/2023	What diuretic is present in standard formulations of dantrolene? {{c1::mannitol}}
Published	12/13/2023	The differential diagnosis of a patient who presents with malignant hyperthermia includes {{c2::thyroid storm}}, which is differentiated from MH …
Published	12/13/2023	The differential diagnosis of a patient who presents with malignant hyperthermia includes {{c2::pheochromocytoma}}, which is differentiated from …
Published	12/13/2023	Genetic testing for {{c1::RYR1}} mutations is a high-{{c2::specificity}} test used to confirm patients with positive caffeine-halothane contractu…
Published	12/13/2023	For patients with a history of malignant hyperthermia, the anesthesia gas machine should be flushed with a fresh gas flow of {{c1::10}} L/min for >…
Published	12/13/2023	For patients with a history of malignant hyperthermia, the {{c1::circuit}} and {{c1::CO2 absorbents}} need to be changed before anesthesia.&…
Published	12/13/2023	Dantrolene can be used to treat two diseases that appear similar to malignant hyperthermia:{{c2::Neuroleptic Malignant Syndrome (NMS)}}{{c1::Thyroid S…
Published	12/13/2023	The differential diagnosis of a patient with malignant hyperthermia includes {{c2::neuroleptic malignant syndrome (NMS)}}, which is differentiated fro…
Published	12/13/2023	The differential diagnosis of a patient with malignant hyperthermia includes {{c2::neuroleptic malignant syndrome (NMS)}}, which is differentiated fro…
Status	Last Update	Fields